According to a recent LinkedIn post from Latent, the company is spotlighting Kristen Kruszewski, Chief Pharmacy Officer at Cone Health, for her role in advancing centralized medication access models. The post highlights improvements in visibility, workflow consistency, and team capacity as key benefits of this centralized approach.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
As described in the post, Cone Health has reportedly expanded centralized coverage from 65 to more than 80 of its highest-prescription-volume clinics while operating with four fewer FTEs. The same model is said to have increased central pharmacy prior-authorization volume and reduced turnaround times, suggesting operational efficiency gains.
For investors, the post suggests that Latent is aligning itself with health systems focused on measurable, scalable pharmacy operations and value-based care efficiencies. Association with leaders presenting at industry forums such as Becker’s Healthcare may enhance Latent’s credibility with potential health system customers and could support future commercial traction if these operational improvements are attributable in part to its solutions.
If Latent’s technology or services underpin some of the reported efficiency metrics, this could indicate a use case with tangible ROI for hospital and clinic clients. Such outcomes, if replicated at scale, may strengthen Latent’s competitive position in the healthcare technology and pharmacy optimization space, potentially improving its long-term revenue prospects and partnership pipeline.

